国产a级特黄的片子,精品香蕉一区二区三区,亚洲精品99久久久久中文字幕,无码精品A∨在线观看无广告

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

CDMO

Macromolecule Drug CDMO Platform

1.Platform Overview
 

Macromolecular platforms comply with GMP Standards of US FDA、EU EMA and NMPA of China. It equipped with 500L/2000L scale production line (designed by NEPHARM, with cGMP standards, equipped with Sartorius Bioreactor, Millipore System and GE Purification System, Bosch washing & drying & irrigation & rolling linkage line, 3M sterilization cabinet and Schneider SCADA Automation Control System).

The core personnel of the platform operation team have more than 15 years  work-experience in Internationale-leading pharmaceutical and biotechnology companies such as KANGHONG, INNOVENT and Bristol-Myers Squibb, and have rich experience in process development and scale-up, process control and quality control, project management, etc., and have experience in the marketing and R&D and production of 8 biological drugs.
 

2.Service Content

The platform can provide stable cell line screening, pilot fermentation process, large-scale culture process and macromolecular purification process development services, antibody drugs, recombinant protein drugs, protein vaccine pilot and large-scale production services and other biological macromolecular pharmaceutical preparations production technical services, support products in China, United States, Europe and other places to conduct clinical trials and rapid marketing, and achieve global synchronous transformation of customer research results.


3.Reality view
 

 

 

Small Molecule Drug CDMO Platform
 

1.Platform Overview

Zhengzhou Pioneerpharm Pharmaceutical Co., Ltd. (Small Molecule API & Preparation CDMO Platform) is an organic part of the Lifezhengzhou · Leadingpharm CXO System. It is jointly built by Leadingpharm, Beijing Chempion Biology and Lifezhengzhou Biomedical Park, provideing technical services related to small molecule industrialization and clinical sample preparation for national pharmaceutical enterprises.
The platform complies with GMP standards of FDA and NMPA, with a total construction area of 6651.54㎡. It is equipped with three preparation workshops (oral solid preparation workshop, small volume injection workshop and oral solution workshop), with supporting power center, storage, quality inspection and other institutions or facilities.

2.Service Content

The platform provides a qualified site for the production of clinical samples of innovative drugs, commercial production of rare disease drugs, pilot test and commercial production of imitation drugs. The dosage forms include tablets, capsules, granules, oral liquid, small volume injection and other conventional oral and injection dosage forms.
The platform can produce 200 million preparation units of solid preparations, 15 million preparation units of injections, 12 million preparation units of oral liquid, 60 pilot projects and 1000 batches of testing per year, enabling innovative enterprises to break through bottlenecks and grow at a high speed.

3.Reality view

 




 

 

 

 

 

日日碰狠狠躁久久躁| 一本大道久久东京热无码av| 亚洲国产另类久久久精品黑人 | 国产精品久久久久久岛| 精品人妻大屁股白浆无码| 久久精品国产99国产精偷| 亚洲中文字幕无码专区| 欧美亚洲日韩国产区一| 伊人久久大香线蕉亚洲五月天| 亚洲国产精品无码专区网站 | 国产成熟妇女性视频电影| 国产精品国产三级国产普通话 | 久久偷看各类wc女厕嘘嘘| 人妻精品久久久久中文字幕| 丰满少妇人妻久久久久久| 国产三级精品三级| 99精产国品一二三产区区别电影| 欧美+国产+日产| 97久久精品人人槡人妻人| 熟女大屁股白浆一区二区| 亲子乱av一区二区三区| 久碰人妻人妻人妻人妻人掠| 午夜精品久久久久久久99热| 久久久av男人的天堂| 强睡邻居人妻中文字幕| 五月av综合av国产av| 国产精品毛片av一区二区三区| 久久夜色精品国产亚洲av动态图| 自由 日本语 热 亚洲人| 熟妇内谢69xxxxxa片| 亚洲国产av精品一区二区蜜芽| 免费视频在线观看爱| 亚洲精品色午夜无码专区日韩| 在线观看的资源视频| 精品国产污污免费网站入口| chinese国产avvideoxxxx实拍 | 无码专区AAAAAA免费视频| 精品国产v无码大片在线观看| 国内熟女精品熟女a片视频小说| 色噜噜狠狠一区二区三区果冻 | 国产精品女同久久久久电影院|